Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 343

Cited In for PubMed (Select 16728594)

1.

REDOX IMAGING OF THE p53-DEPENDENT MITOCHONDRIAL REDOX STATE IN COLON CANCER EX VIVO.

Xu HN, Feng M, Moon L, Dolloff N, El-Deiry W, Li LZ.

J Innov Opt Health Sci. 2013 Jul;6(3). pii: 1350016.

2.

Resveratrol: A Focus on Several Neurodegenerative Diseases.

Tellone E, Galtieri A, Russo A, Giardina B, Ficarra S.

Oxid Med Cell Longev. 2015;2015:392169. doi: 10.1155/2015/392169. Epub 2015 Jun 9. Review.

3.

Regulation of nucleotide metabolism by mutant p53 contributes to its gain-of-function activities.

Kollareddy M, Dimitrova E, Vallabhaneni KC, Chan A, Le T, Chauhan KM, Carrero ZI, Ramakrishnan G, Watabe K, Haupt Y, Haupt S, Pochampally R, Boss GR, Romero DG, Radu CG, Martinez LA.

Nat Commun. 2015 Jun 12;6:7389. doi: 10.1038/ncomms8389.

PMID:
26067754
4.

Spatial profiles of markers of glycolysis, mitochondria, and proton pumps in a rat glioma suggest coordinated programming for proliferation.

Grillon E, Farion R, Reuveni M, Glidle A, Rémy C, Coles JA.

BMC Res Notes. 2015 Jun 2;8:207. doi: 10.1186/s13104-015-1191-z.

5.

Metabolic Signatures of Human Breast Cancer.

Mishra P, Ambs S.

Mol Cell Oncol. 2015 Jul-Sep;2(3). pii: e992217.

6.

Molecular Connections between Cancer Cell Metabolism and the Tumor Microenvironment.

Justus CR, Sanderlin EJ, Yang LV.

Int J Mol Sci. 2015 May 15;16(5):11055-86. doi: 10.3390/ijms160511055. Review.

7.

Hyperoxia activates ATM independent from mitochondrial ROS and dysfunction.

Resseguie EA, Staversky RJ, Brookes PS, O'Reilly MA.

Redox Biol. 2015 May 2;5:176-185. doi: 10.1016/j.redox.2015.04.012. [Epub ahead of print]

8.

Diabetes and its link with cancer: providing the fuel and spark to launch an aggressive growth regime.

Joshi S, Liu M, Turner N.

Biomed Res Int. 2015;2015:390863. doi: 10.1155/2015/390863. Epub 2015 Apr 15. Review.

9.

Oroxylin A promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cells.

Zhao K, Zhou Y, Qiao C, Ni T, Li Z, Wang X, Guo Q, Lu N, Wei L.

J Hematol Oncol. 2015 Apr 23;8:41. doi: 10.1186/s13045-015-0137-1.

10.

New perspective on targeting the tumor suppressor p53 pathway in the tumor microenvironment to enhance the efficacy of immunotherapy.

Guo G, Cui Y.

J Immunother Cancer. 2015 Mar 24;3:9. doi: 10.1186/s40425-015-0053-5. eCollection 2015.

11.

p53 enables metabolic fitness and self-renewal of nephron progenitor cells.

Li Y, Liu J, Li W, Brown A, Baddoo M, Li M, Carroll T, Oxburgh L, Feng Y, Saifudeen Z.

Development. 2015 Apr 1;142(7):1228-41. doi: 10.1242/dev.111617.

PMID:
25804735
12.

Cardiac deficiency of single cytochrome oxidase assembly factor scox induces p53-dependent apoptosis in a Drosophila cardiomyopathy model.

Martínez-Morentin L, Martínez L, Piloto S, Yang H, Schon EA, Garesse R, Bodmer R, Ocorr K, Cervera M, Arredondo JJ.

Hum Mol Genet. 2015 Jul 1;24(13):3608-22. doi: 10.1093/hmg/ddv106. Epub 2015 Mar 19.

PMID:
25792727
13.

Analysis of p53 transactivation domain mutants reveals Acad11 as a metabolic target important for p53 pro-survival function.

Jiang D, LaGory EL, Kenzelmann Brož D, Bieging KT, Brady CA, Link N, Abrams JM, Giaccia AJ, Attardi LD.

Cell Rep. 2015 Feb 24;10(7):1096-109. doi: 10.1016/j.celrep.2015.01.043. Epub 2015 Feb 19.

14.

Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters.

Urayama S.

World J Gastroenterol. 2015 Feb 14;21(6):1707-17. doi: 10.3748/wjg.v21.i6.1707. Review.

15.

Cellular and molecular biology of aging endothelial cells.

Donato AJ, Morgan RG, Walker AE, Lesniewski LA.

J Mol Cell Cardiol. 2015 Feb 2. pii: S0022-2828(15)00034-6. doi: 10.1016/j.yjmcc.2015.01.021. [Epub ahead of print] Review.

PMID:
25655936
16.

Silencing gastrin-releasing peptide receptor suppresses key regulators of aerobic glycolysis in neuroblastoma cells.

Rellinger EJ, Romain C, Choi S, Qiao J, Chung DH.

Pediatr Blood Cancer. 2015 Apr;62(4):581-6. doi: 10.1002/pbc.25348. Epub 2015 Jan 28.

PMID:
25630799
17.

Personalized preventive medicine: genetics and the response to regular exercise in preventive interventions.

Bouchard C, Antunes-Correa LM, Ashley EA, Franklin N, Hwang PM, Mattsson CM, Negrao CE, Phillips SA, Sarzynski MA, Wang PY, Wheeler MT.

Prog Cardiovasc Dis. 2015 Jan-Feb;57(4):337-46. doi: 10.1016/j.pcad.2014.08.005. Epub 2014 Aug 13. Review.

PMID:
25559061
18.

Dichloroacetate, a selective mitochondria-targeting drug for oral squamous cell carcinoma: a metabolic perspective of treatment.

Ruggieri V, Agriesti F, Scrima R, Laurenzana I, Perrone D, Tataranni T, Mazzoccoli C, Lo Muzio L, Capitanio N, Piccoli C.

Oncotarget. 2015 Jan 20;6(2):1217-30.

19.

Tumor mechanics and metabolic dysfunction.

Tung JC, Barnes JM, Desai SR, Sistrunk C, Conklin MW, Schedin P, Eliceiri KW, Keely PJ, Seewaldt VL, Weaver VM.

Free Radic Biol Med. 2015 Feb;79:269-80. doi: 10.1016/j.freeradbiomed.2014.11.020. Epub 2014 Dec 19. Review.

PMID:
25532934
20.

TIGAR regulates glycolysis in ischemic kidney proximal tubules.

Kim J, Devalaraja-Narashimha K, Padanilam BJ.

Am J Physiol Renal Physiol. 2015 Feb 15;308(4):F298-308. doi: 10.1152/ajprenal.00459.2014. Epub 2014 Dec 10.

PMID:
25503731
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk